190 related articles for article (PubMed ID: 27038327)
1. Insights Into the Allosteric Inhibition of the SUMO E2 Enzyme Ubc9.
Hewitt WM; Lountos GT; Zlotkowski K; Dahlhauser SD; Saunders LB; Needle D; Tropea JE; Zhan C; Wei G; Ma B; Nussinov R; Waugh DS; Schneekloth JS
Angew Chem Int Ed Engl; 2016 May; 55(19):5703-7. PubMed ID: 27038327
[TBL] [Abstract][Full Text] [Related]
2. Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation.
Wiechmann S; Gärtner A; Kniss A; Stengl A; Behrends C; Rogov VV; Rodriguez MS; Dötsch V; Müller S; Ernst A
J Biol Chem; 2017 Sep; 292(37):15340-15351. PubMed ID: 28784659
[TBL] [Abstract][Full Text] [Related]
3. Alternative allosteric mechanisms can regulate the substrate and E2 in SUMO conjugation.
Karaca E; Tozluoğlu M; Nussinov R; Haliloğlu T
J Mol Biol; 2011 Mar; 406(4):620-30. PubMed ID: 21216249
[TBL] [Abstract][Full Text] [Related]
4. A Small-Molecule Microarray Approach for the Identification of E2 Enzyme Inhibitors in Ubiquitin-Like Conjugation Pathways.
Zlotkowski K; Hewitt WM; Sinniah RS; Tropea JE; Needle D; Lountos GT; Barchi JJ; Waugh DS; Schneekloth JS
SLAS Discov; 2017 Jul; 22(6):760-766. PubMed ID: 28346086
[TBL] [Abstract][Full Text] [Related]
5. Role of an N-terminal site of Ubc9 in SUMO-1, -2, and -3 binding and conjugation.
Tatham MH; Kim S; Yu B; Jaffray E; Song J; Zheng J; Rodriguez MS; Hay RT; Chen Y
Biochemistry; 2003 Aug; 42(33):9959-69. PubMed ID: 12924945
[TBL] [Abstract][Full Text] [Related]
6. Ubc9 sumoylation controls SUMO chain formation and meiotic synapsis in Saccharomyces cerevisiae.
Klug H; Xaver M; Chaugule VK; Koidl S; Mittler G; Klein F; Pichler A
Mol Cell; 2013 Jun; 50(5):625-36. PubMed ID: 23644018
[TBL] [Abstract][Full Text] [Related]
7. A mechanistic view of the role of E3 in sumoylation.
Tozluoğlu M; Karaca E; Nussinov R; Haliloğlu T
PLoS Comput Biol; 2010 Aug; 6(8):. PubMed ID: 20865051
[TBL] [Abstract][Full Text] [Related]
8. RWD Domain as an E2 (Ubc9)-Interaction Module.
Alontaga AY; Ambaye ND; Li YJ; Vega R; Chen CH; Bzymek KP; Williams JC; Hu W; Chen Y
J Biol Chem; 2015 Jul; 290(27):16550-9. PubMed ID: 25918163
[TBL] [Abstract][Full Text] [Related]
9. Structural insights into the regulation of the human E2∼SUMO conjugate through analysis of its stable mimetic.
Goffinont S; Coste F; Prieu-Serandon P; Mance L; Gaudon V; Garnier N; Castaing B; Suskiewicz MJ
J Biol Chem; 2023 Jul; 299(7):104870. PubMed ID: 37247759
[TBL] [Abstract][Full Text] [Related]
10. Identification of sumoylation inhibitors targeting a predicted pocket in Ubc9.
Kumar A; Ito A; Hirohama M; Yoshida M; Zhang KY
J Chem Inf Model; 2014 Oct; 54(10):2784-93. PubMed ID: 25191977
[TBL] [Abstract][Full Text] [Related]
11. Unique binding interactions among Ubc9, SUMO and RanBP2 reveal a mechanism for SUMO paralog selection.
Tatham MH; Kim S; Jaffray E; Song J; Chen Y; Hay RT
Nat Struct Mol Biol; 2005 Jan; 12(1):67-74. PubMed ID: 15608651
[TBL] [Abstract][Full Text] [Related]
12. Ubc9 sumoylation regulates SUMO target discrimination.
Knipscheer P; Flotho A; Klug H; Olsen JV; van Dijk WJ; Fish A; Johnson ES; Mann M; Sixma TK; Pichler A
Mol Cell; 2008 Aug; 31(3):371-82. PubMed ID: 18691969
[TBL] [Abstract][Full Text] [Related]
13. Identification of a non-covalent ternary complex formed by PIAS1, SUMO1, and UBC9 proteins involved in transcriptional regulation.
Mascle XH; Lussier-Price M; Cappadocia L; Estephan P; Raiola L; Omichinski JG; Aubry M
J Biol Chem; 2013 Dec; 288(51):36312-27. PubMed ID: 24174529
[TBL] [Abstract][Full Text] [Related]
14. Biochemical characterization of SUMO-conjugating enzymes by in vitro sumoylation assays.
Eisenhardt N; Ilic D; Nagamalleswari E; Pichler A
Methods Enzymol; 2019; 618():167-185. PubMed ID: 30850051
[TBL] [Abstract][Full Text] [Related]
15. Ubc9 acetylation modulates distinct SUMO target modification and hypoxia response.
Hsieh YL; Kuo HY; Chang CC; Naik MT; Liao PH; Ho CC; Huang TC; Jeng JC; Hsu PH; Tsai MD; Huang TH; Shih HM
EMBO J; 2013 Mar; 32(6):791-804. PubMed ID: 23395904
[TBL] [Abstract][Full Text] [Related]
16. Purification and activity assays for Ubc9, the ubiquitin-conjugating enzyme for the small ubiquitin-like modifier SUMO.
Yunus AA; Lima CD
Methods Enzymol; 2005; 398():74-87. PubMed ID: 16275321
[TBL] [Abstract][Full Text] [Related]
17. Is Transthyretin a Regulator of Ubc9 SUMOylation?
Wieczorek E; Kędracka-Krok S; Sołtys K; Jankowska U; Hołubowicz R; Seliga J; Ożyhar A
PLoS One; 2016; 11(8):e0160536. PubMed ID: 27501389
[TBL] [Abstract][Full Text] [Related]
18. DNA repair and global sumoylation are regulated by distinct Ubc9 noncovalent complexes.
Prudden J; Perry JJ; Nie M; Vashisht AA; Arvai AS; Hitomi C; Guenther G; Wohlschlegel JA; Tainer JA; Boddy MN
Mol Cell Biol; 2011 Jun; 31(11):2299-310. PubMed ID: 21444718
[TBL] [Abstract][Full Text] [Related]
19. An in vitro Förster resonance energy transfer-based high-throughput screening assay identifies inhibitors of SUMOylation E2 Ubc9.
Wang YZ; Liu X; Way G; Madarha V; Zhou QT; Yang DH; Liao JY; Wang MW
Acta Pharmacol Sin; 2020 Nov; 41(11):1497-1506. PubMed ID: 32341466
[TBL] [Abstract][Full Text] [Related]
20. The B-box1 domain of PML mediates SUMO E2-E3 complex formation through an atypical interaction with UBC9.
Bregnard T; Ahmed A; Semenova IV; Weller SK; Bezsonova I
Biophys Chem; 2022 Aug; 287():106827. PubMed ID: 35667129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
